Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liesbet Vervoort

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Protein Engineering, Design & Selection : PEDS|July 10, 2010
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1Steve Schoonooghe, Ingrid Burvenich, Liesbet Vervoort, et al.
Drug Discovery Today|January 14, 2015
Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR projectBie Verbist, Günter Klambauer, Liesbet Vervoort, et al.
Nuclear Medicine and Biology|March 27, 2007
Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumorIngrid J G Burvenich, Steve Schoonooghe, Peter Blanckaert, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Breast Cancer Research and Treatment|April 9, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancerLuc Dirix, Andy Buys, Steffy Oeyen, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 22, 2010
Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agentMagali Van Steenkiste, Ruth Oltenfreiter, Francis Frankenne, et al.
Molecular Cancer Therapeutics|December 17, 2008
Monoclonal antibody 14C5 targets integrin alphavbeta5Ingrid Burvenich, Steve Schoonooghe, Liesbet Vervoort, et al.
Translational Lung Cancer Research|May 17, 2023
False positivity in break apart fluorescence in-situ hybridization due to polyploidyAnna Lena van Gulik, Ellen Sluydts, Liesbet Vervoort, et al.
Chemical Research in Toxicology|August 28, 2015
Integrating High-Dimensional Transcriptomics and Image Analysis Tools into Early Safety Screening: Proof of Concept for a New Early Drug Development StrategyBie M P Verbist, Geert R Verheyen, Liesbet Vervoort, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|July 10, 2010
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1Steve Schoonooghe, Ingrid Burvenich, Liesbet Vervoort, et al.
Drug Discovery Today|January 14, 2015
Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR projectBie Verbist, Günter Klambauer, Liesbet Vervoort, et al.
Nuclear Medicine and Biology|March 27, 2007
Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumorIngrid J G Burvenich, Steve Schoonooghe, Peter Blanckaert, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Breast Cancer Research and Treatment|April 9, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancerLuc Dirix, Andy Buys, Steffy Oeyen, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 22, 2010
Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agentMagali Van Steenkiste, Ruth Oltenfreiter, Francis Frankenne, et al.
Molecular Cancer Therapeutics|December 17, 2008
Monoclonal antibody 14C5 targets integrin alphavbeta5Ingrid Burvenich, Steve Schoonooghe, Liesbet Vervoort, et al.
Translational Lung Cancer Research|May 17, 2023
False positivity in break apart fluorescence in-situ hybridization due to polyploidyAnna Lena van Gulik, Ellen Sluydts, Liesbet Vervoort, et al.
Chemical Research in Toxicology|August 28, 2015
Integrating High-Dimensional Transcriptomics and Image Analysis Tools into Early Safety Screening: Proof of Concept for a New Early Drug Development StrategyBie M P Verbist, Geert R Verheyen, Liesbet Vervoort, et al.
Pageof 1